1-12 of 12
Liviu Niculescu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tourmaline US-MM6, an Open-Label, Single-Arm, Multicenter Study Evaluating the Effectiveness and Safety of Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) in Patients (pts) with Newly Diagnosed Multiple Myeloma (NDMM) Switching from a Bortezomib-Based Triplet Induction Regimen

Robert M Rifkin, MD, Ralph V. Boccia, MD, Suman Kambhampati, MD, Joshua R Richter, MD, Saad Z Usmani, MD, Jack Aiello, EE, MS, BS, Brittany Sickler, BA, BS, Magdalena Schoeneich, MBA, MS, Bingxia Wang, PhD, Susan Zelt, PhD, Presley Whidden, MS, Lawrence E Dollar, PharmD, MS, Liviu Niculescu, MD, Stephen J Noga, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5407.
https://doi.org/10.1182/blood.V130.Suppl_1.5407.5407
Published: 2017
Journal Articles

Uncovering the Blind Spot of Clinical Trials: First Report of Baseline Characteristics of Newly Diagnosed (ND) and Relapsed/Refractory (RR) Multiple Myeloma (MM) Patients (Pts) in Insight-MM, a Global, Prospective, Observational Study

Evangelos Terpos, MD PhD, Ajai Chari, MD, Robert M Rifkin, MD, Rafat Abonour, MD, Jesus G. Berdeja, MD, Mario Boccadoro, Gordon Cook, MD PhD, Caitlin Costello, MD, Saulius Girnius, MD, Hartmut Goldschmidt, MD, Roman Hájek, MD, Vania T M Hungria, MD PhD, Hans C. Lee, MD, Xavier Leleu, MD PhD, Jim Omel, MD, Andrew Spencer, MD, Michael A Thompson, MD, Saad Z Usmani, MD, Jorge Vela-Ojeda, MD PhD, Jeffrey A Zonder, MD, Liviu Niculescu, MD, Stephen Noga, MD, Tomas Skacel, MD, Roxanne Cacioppo, Brittany Sickler, BA, BS, Shawn Yu, Kaili Ren, PhD, Katarina Luptakova, MD, Dawn Marie Stull, Faith E. Davies, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5419.
https://doi.org/10.1182/blood.V130.Suppl_1.5419.5419
Published: 2017
Journal Articles

Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients: The Insight-MM Study

Robert M Rifkin, Faith E Davies, MD, Antonio Palumbo, MD, Jeffrey Zonder, MD, Saulius K Girnius, MD, Caitlin L Costello, MD, Saad Z Usmani, MD FACP, Jesus G. Berdeja, MD, Jim Omel, Michael A Thompson, MD PhD, Jatin Shah, MD, J Sanford Schwartz, Roman Hajek, MD, Evangelos Terpos, MD PhD, Vânia Hungria, MD PhD, Maria-Victoria Mateos, MD PhD, Gordon Cook, Xavier Leleu, Andrew Spencer, Hartmut Goldschmidt, MD, Brian Seal, RPh, MBA, PhD, Chris L Pashos, PhD, Dawn Marie Stull, PharmD, FRACP, Dorothy Romanus, RPh, MSc, PhD, Roxanne Cacioppo, Jill A Bell, PhD, Shawn Yu, Katarina Luptakova, Liviu Niculescu, MD PhD, Stephen J Noga, Tomas Skacel, Ajai Chari, MD
Journal: Blood
Blood (2016) 128 (22): 5681.
https://doi.org/10.1182/blood.V128.22.5681.5681
Published: 2016
Journal Articles

Comparative Effectiveness Research on the Treatment Outcomes of Subcutaneous (SC) and Intravenous (IV) Bortezomib (BTZ) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts)

Robert M. Rifkin, Esprit Ma, MPH, Robyn Harrell, MS, Yanyan Zhu, PhD MPH, Edward Dow, MD, Liviu Niculescu, MDPhD, Vijayveer Bonthapally, PhD
Journal: Blood
Blood (2015) 126 (23): 4506.
https://doi.org/10.1182/blood.V126.23.4506.4506
Published: 2015
Journal Articles

Subcutaneous (SQ) Bortezomib (BTZ) in Patients (Pts) with Relapsed Mantle Cell Lymphoma (MCL): Retrospective, Observational Study of Treatment Patterns and Outcomes in US Community Oncology Practices

Alan P Skarbnik, MD, Esprit Ma, MPH, Marie-Hélène Lafeuille, MA, Jonathan Fortier, MA, Tatyana Feldman, MD, Mei Sheng Duh, MPH, ScD, Yvette Ng, MS, MBA, Helgi van de Velde, MD PhD, Edward Dow, MD, Liviu Niculescu, MD, Vijayveer Bonthapally, PhD, Andre Goy, MD MS
Journal: Blood
Blood (2014) 124 (21): 1740.
https://doi.org/10.1182/blood.V124.21.1740.1740
Published: 2014
Journal Articles

Impact Of Route Of Bortezomib (B) Administration On Dose Intensity and Time To Dose Reduction In Previously Untreated Patients (Pts) With Multiple Myeloma (MM)

Robert M Rifkin, MD, FACP, Clara Chen, MS, Rahul Dhanda, Ph.D, Debra Rembert, RN, MSN, NP, Abbie Ba-Mancini, BS MBA, Esprit Ma, MPH, Yanyan Zhu, Ph.D, MPH, Edward Dow, MD, Liviu Niculescu, MD
Journal: Blood
Blood (2013) 122 (21): 1941.
https://doi.org/10.1182/blood.V122.21.1941.1941
Published: 2013
Journal Articles

Efficacy and Safety Of Three Bortezomib-Based Induction and Maintenance Regimens In Previously Untreated, Transplant-Ineligible Multiple Myeloma (MM) Patients (Pts): Final Results From The Randomized, Phase 3b, US Community-Based UPFRONT Study (NCT00507416)

Ruben Niesvizky, MD, Ian Flinn, MD, PhD, Robert M. Rifkin, MD, James Essell, MD, Yousuf Gaffar, MD, Thomas Warr, MD, Rachel Neuwirth, Ph.D, Abbie Ba-Mancini, BS MBA, Yanyan Zhu, Ph.D, MPH, Liviu Niculescu, MD, James Reeves, MD
Journal: Blood
Blood (2013) 122 (21): 1966.
https://doi.org/10.1182/blood.V122.21.1966.1966
Published: 2013
Journal Articles

Higher Cumulative Bortezomib Dose Results In Better Overall Survival (OS) In Patients With Previously Untreated Multiple Myeloma (MM) Receiving Bortezomib-Melphalan-Prednisone (VMP) In The Phase 3 VISTA Study

Maria-Victoria Mateos, MD, Ph.D, Paul G. Richardson, MD, Hongliang Shi, Ph.D, Liviu Niculescu, MD, Jennifer Elliott, Ph.D, Edward Dow, MD, Helgi van de Velde, Jesús F San Miguel, MD
Journal: Blood
Blood (2013) 122 (21): 1968.
https://doi.org/10.1182/blood.V122.21.1968.1968
Published: 2013
Journal Articles

Comparable Outcomes With Bortezomib-Cyclophosphamide-Dexamethasone (VCD) and Bortezomib-Lenalidomide-Dexamethasone (VRD) For Initial Treatment Of Newly Diagnosed Multiple Myeloma (MM)

Shaji K Kumar, MD, Ann E Engebretson, Francis K Buadi, MD, Martha Q Lacy, MD, Angela Dispenzieri, MD, Mei Sheng Duh, MPH, Sc.D, Marie-Hélène Lafeuille, MA, Patrick Lefebvre, MA, B.Sc, Wendy Y Cheng, MPH, MPhil, Katherine Dea, MA, Mark Yap, BSN, RN, Shanmugapriya Saravanan, MS, Iwen Pan, Ph.D, Debra Rembert, RN, MSN, NP, Rahul Dhanda, PhD, Liviu Niculescu, MD, Abbie Ba-Mancini, BS MBA, Esprit Ma, MPH, Maureen Quick, RN, MS, OCN, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2013) 122 (21): 3178.
https://doi.org/10.1182/blood.V122.21.3178.3178
Published: 2013
Journal Articles

Quantifying The Risk Of Heart Failure Associated With Proteasome Inhibition: A Retrospective Analysis Of Heart Failure Reported In Phase 2 and Phase 3 Studies Of Bortezomib (Btz) In Multiple Myeloma (MM)

Jacob P. Laubach, MD, Jesús F San Miguel, MD, Pieter Sonneveld, MD, Ph.D, Robert Z. Orlowski, M.D., Ph.D., Philippe Moreau, MD, Laura Rosiñol, MD, Javid J Moslehi, MD, Edward A Faber, Jr., DO, MS, Peter M Voorhees, Loreta Marquez, MD, Avinash Desai, MD, Helgi van de Velde, Jennifer Elliott, Ph.D, Hongliang Shi, Ph.D, Edward Dow, MD, Nishith Jobanputra, DO, Dixie-Lee Esseltine, MD, FRCPC, Liviu Niculescu, MD, Kenneth C. Anderson, MD, Sagar Lonial, M.D., Paul G. Richardson, MD
Journal: Blood
Blood (2013) 122 (21): 3187.
https://doi.org/10.1182/blood.V122.21.3187.3187
Published: 2013
Journal Articles

Meta-Analysis of the Efficacy and Safety of Bortezomib Retreatment in Patients with Multiple Myeloma (MM)

Kevin B Knopf, MD, Mei Sheng Duh, ScD, MPH, Marie-Hélène Lafeuille, MA, Jonathan Gravel, Patrick Lefebvre, MA, Liviu Niculescu, Abbie Ba-Mancini, BS, MBA, Esprit Ma, Hongliang Shi, MS, Raymond L. Comenzo, MD
Journal: Blood
Blood (2012) 120 (21): 1863.
https://doi.org/10.1182/blood.V120.21.1863.1863
Published: 2012
Journal Articles

Integrated Safety Analysis of Single-Agent MLN8237 (alisertib), an Investigational Aurora A Kinase Inhibitor, in Patients with Advanced Hematologic Malignancies and Solid Tumors

Ely Benaim, MD, Xiaofei Zhou, PhD, Hua Liu, PhD, E. Jane Leonard, MSc, Eric Freedland, Liviu Niculescu
Journal: Blood
Blood (2012) 120 (21): 3683.
https://doi.org/10.1182/blood.V120.21.3683.3683
Published: 2012